MoneyWorks4Me

IOL Chemicals and Pharmaceuticals informs about outcome of board meeting

28 Oct 2024 Evaluate

Pursuant to the provisions of the Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), IOL Chemicals and Pharmaceuticals has informed that the Board of Directors of the Company, at their Meeting held today 28th October 2024,approved the following: 1. Appointment of Rajni Jha (DIN: 10818947) as an Additional and Independent Director of the Company for a term of three years, with effect from 28th October 2024, subject to approval of Members of the Company. The details as required under Regulation 30 of the Listing Regulations read with SEBI Circular dated 13th July 2023 are enclosed as ‘Annexure A’. Pursuant to the BSE and NSE circulars dated 20th June 2018, it has affirmed that Rajni Jha is not debarred from holding office of a director by virtue of any order of the Securities and Exchange Board of India or any other such authority. 2. Approved the Postal Ballot Notice to seek the approval of the shareholders through Postal Ballot for appointment of Rajni Jha as Independent Director of the Company. Postal Ballot Notice shall be sent to the shareholders in due course and the same shall be filed with the exchanges. The Board also reconstituted the Nomination & Remuneration Committee and Stakeholders’ Relationship Committee of the Board. The meeting commenced at 11:00 am and concluded at 12.05 pm. The above information will be made available on the website of the Company at www.iolcp.com.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.55
Dr. Reddys Labs. 1141.00
Cipla 1366.30
Lupin 2075.00
Zydus Lifesciences 1113.45
View more..